Proteostasis control via HSP90α sustains YAP activity to drive aggressive behaviours in cancer-associated fibroblasts
Dominguez-Garcia, S.; Rodriguez, J.; Julia, M.; Coursier, D.; Perez-Lopez, C.; Carnicero, P.; Villar, A. V.; von Kriegsheim, A.; Calvo, F.
Show abstract
Cancers adapt proteostasis to cope with the burden of misfolded proteins, stabilize key signalling nodes and sustain their malignant behaviour. Tumour stroma is subjected to similar stresses, but how they influence its aberrant status remains unclear. We show that tumour stroma presents consistent upregulation of target genes associated to the major misfolding regulator HSP90 in cancer-associated fibroblasts (CAFs), and that HSP90 is required for CAFs to remodel the extracellular matrix (ECM) and promote cancer cell motility and growth. Mechanistically, HSP90 sustains TGF{beta} responses and YAP protein levels required for CAF functionality. In vivo, stromal or fibroblast-specific loss of HSP90 results in reduced ECM deposition, angiogenesis, growth and dissemination of breast tumours. Clinical analyses reveal a correlation between HSP90-dependent programs and YAP activity in CAFs, that are also associated with poor patient prognosis. Our findings uncover a link between proteostasis, mechanotransduction and generation of aggressive tumour microenvironments through HSP90.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Inhibition of the YAP-MMB interaction and targeting NEK2 as potential therapeutic strategies for YAP-driven cancers 96%
- EWS::FLI1-DHX9 interaction promotes Ewing sarcoma sensitivity to DNA topoisomerase 1 poisons by altering R-loop metabolism 95%
- The scaffold protein IQGAP1 links heat-induced stress signals to alternative splicing regulation in gastric cancer cells 95%
Similar papers in this journal
- Unraveling the YAP1-TGFβ1 axis: a key driver of androgen receptor loss in prostate cancer-associated fibroblasts 95%
- In vitro models to mimic tumor endothelial cell-mediated immune cell reprogramming in lung adenocarcinoma 95%
- Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors 95%
Similar papers in this journal
- RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR. 96%
- RIPK3 upregulation confers robust proliferation and collateral cystine-dependence on breast cancer recurrence 96%
- Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification 96%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.